加拿大原住民早期类风湿关节炎表现、治疗与结局比较
基于加拿大早期关节炎队列(2,173例,原住民100例、白人2,073例)比较两组早期类风湿关节炎的表现、治疗与结局。基线症状持续时间、DAS28和HAQ相似,治疗选择与升级频率相近,但原住民DAS28缓解率更低(校正OR 0.39,95%CI 0.25-0.62),疼痛水平持续更高。
要点
- 原住民早期RA的DAS28缓解率显著低于白人(校正OR 0.39,95%CI 0.25-0.62)。
- 两组基线DAS28(4.87±1.48)与HAQ(0.88±0.68)相似,症状持续时间均约179±91天。
- 两组改善病情药物选择与升级频率相似,但原住民肿胀关节计数改善更慢、疼痛更高。
核心结论
- 原住民早期RA患者疾病结局差于白人,可能与未测量的生物学差异及健康决定因素不平等等所致预后因素差异有关。
研究设计与样本
- 加拿大早期关节炎队列(Canadian Early Arthritis Cohort)前瞻性多中心早期RA研究的纵向数据分析,纳入自报原住民或白人种族的参与者共2,173例(原住民100例、白人2,073例)。
主要发现
- 基线时两组平均症状持续时间179±91天、DAS28 4.87±1.48、HAQ 0.88±0.68相似。
- 原住民参与者中不良预后因素更常见,但两组改善病情治疗选择与治疗升级频率相似。
- 原住民DAS28缓解率更低(校正OR 0.39,95%CI 0.25-0.62),主要由肿胀关节计数改善更慢及患者总体评分改善不显著驱动。
- 原住民患者疼痛水平持续更高。
关键数值与推荐
- DAS28缓解:原住民 vs 白人校正OR 0.39(95%CI 0.25-0.62)。
临床怎么用
- 应关注原住民早期RA患者较低的缓解率与持续较高疼痛,审视现行治疗策略在不同情境下的适用性。
局限性
- 原文未报告具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Health inequities exist in chronic diseases for Aboriginal people. This study compared early rheumatoid arthritis (RA) presentation, treatment, and outcomes between Aboriginal and white patients in a large Canadian cohort study. METHODS: Longitudinal data from the Canadian Early Arthritis Cohort, a prospective multicenter early RA study, were analyzed for participants who self-identified as Aboriginal or white ethnicity. Disease characteristics at presentation, prognostic factors, frequency of remission, and disease-modifying therapy strategies were contrasted between population groups. Linear mixed models were used to estimate rates of change for disease activity measures over a 5-year period. RESULTS: At baseline, 2,173 participants (100 Aboriginal and 2,073 white) had similar mean ± SD symptom duration (179 ± 91 days), 28-joint Disease Activity Scores (DAS28; 4.87 ± 1.48), and Health Assessment Questionnaire (0.88 ± 0.68) scores. Factors associated with poor prognosis were more frequently present in Aboriginal participants, but disease-modifying therapy selection and frequency of therapy escalation was similar between the 2 groups. DAS28 remission was achieved less frequently in Aboriginal than in white participants (adjusted odds ratio 0.39 [95% confidence interval 0.25-0.62]). Results were primarily driven by slower improvement in swollen joint counts and nonsignificant improvement in patient global scores in Aboriginal participants. Pain levels remained higher in Aboriginal patients. CONCLUSION: Aboriginal early RA patients experienced worse disease outcomes than their white counterparts. This may reflect unmeasured biologic differences and/or disparities in prognostic factors informed by inequities in determinants of health. The appropriateness of current treatment strategies applied in different contexts should be considered.
引用
- Nagaraj S, Barnabe C, Schieir O, et al. Early Rheumatoid Arthritis Presentation, Treatment, and Outcomes in Aboriginal Patients in Canada: A Canadian Early Arthritis Cohort Study Analysis. Arthritis Care Res (Hoboken). 2018. PMID: 29125904. doi:10.1002/acr.23470
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。